Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
55,400,378
-
Share change
-
-833,150
-
Total reported value
-
$9,303,697,145
-
Put/Call ratio
-
228%
-
Price per share
-
$168.13
-
Number of holders
-
397
-
Value change
-
-$146,566,478
-
Number of buys
-
205
-
Number of sells
-
167
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q3 2018
As of 30 Sep 2018,
Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by
397 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
55,400,378 shares.
The largest 10 holders included
FMR LLC, Vanguard Group Inc, BlackRock Inc., PUTNAM INVESTMENTS LLC, JPMORGAN CHASE & CO, Bank of New York Mellon Corp, TIAA CREF INVESTMENT MANAGEMENT LLC, STATE STREET CORP, Boston Partners, and WESTFIELD CAPITAL MANAGEMENT CO LP.
This page lists
398
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.